B · Normal
[Dongcheng Pharmaceutical: Plans to repurchase 34.9232% of the shares held by minority shareholders of its holding subsidiary Lan Nacheng for no more than 1.121 billion yuan] On October 14, Dongcheng Pharmaceutical (002675.SZ) announced that the company plans to repurchase 34.9232% of the shares held by minority shareholders of its holding subsidiary Lan Nacheng for no more than 1.121 billion yuan. After the repurchase, the company's shareholding ratio increased from 43.9502% to 78.8734%. This transaction constitutes a related transaction and does not constitute a major asset restructuring, and it still needs to be submitted to the shareholders' meeting for review.
Comments